How to Use Semaglutide Injections: A Science-Backed Guide for Men

When researchers published the landmark STEP 1 trial in the New England Journal of Medicine, the numbers were hard to ignore. Adults with obesity who used once-weekly subcutaneous semaglutide at 2.4 mg lost an average of 14.9% of their body weight over 68 weeks — compared to just 2.4% in the placebo group. Nearly 70% of participants lost 10% or more of their body weight. For a medication delivered via a weekly self-injection, those results shifted how the medical community thinks about pharmacological obesity treatment. But knowing that semaglutide works is only half the picture. Knowing how to use it correctly — and how to maximize it — is what separates men who get real results from those who stall out or give up at the first side effect.

Semaglutide (sold under the brand names Ozempic for diabetes management and Wegovy for chronic weight management) is a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by mimicking a naturally occurring gut hormone that signals fullness to the brain, slows gastric emptying, and helps regulate blood sugar. For men working to reduce visceral fat, lower cardiometabolic risk markers, or finally break through a stubborn weight plateau, it can be a genuinely powerful clinical tool — when used the right way.

The Injection Protocol: How It Actually Works

Semaglutide for weight management is administered subcutaneously — meaning into the fat layer just beneath the skin — once weekly. The pen-style auto-injector is designed to be as user-friendly as possible, and most men report that the injection itself is nearly painless when done correctly. The standard approved sites are the abdomen (at least two inches from the navel), the front of the thigh, or the upper arm. Rotating injection sites each week helps prevent skin irritation or lipohypertrophy, a localized thickening of the skin that can affect absorption over time.

Timing matters less than consistency. Whether you inject on Monday morning or Saturday evening, the goal is to maintain a steady weekly rhythm. Semaglutide has a half-life of approximately one week, which is exactly why the once-weekly dosing schedule is effective — plasma levels remain relatively stable throughout the week with this cadence. If you miss a dose, the guidance is straightforward: inject as soon as you remember, provided the next scheduled dose is at least two days away. If it is fewer than two days out, skip the missed dose and resume your normal schedule.

The dose escalation protocol is non-negotiable if you want to minimize gastrointestinal side effects. Treatment begins at 0.25 mg per week for the first four weeks — a sub-therapeutic dose designed purely to let your body acclimate. From there, the dose increases every four weeks: 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg as the maintenance dose for weight management. Skipping escalation steps to accelerate results is one of the most common mistakes men make, and it predictably leads to the nausea, vomiting, and diarrhea that drive early discontinuation. Those side effects are not inevitable — they are largely a product of going too fast.

What the Research Tells You About Long-Term Use

One of the most important findings in the semaglutide literature is what happens when you stop. The STEP 4 trial, published in JAMA, followed participants who had already lost an average of 10.6% of their body weight during a 20-week semaglutide run-in period. Those who continued on semaglutide lost an additional 7.9% of body weight over the following 48 weeks. Those who were switched to placebo regained 6.9% — nearly all of their progress — over the same period. The implications are significant: semaglutide is a long-term metabolic therapy, not a short-term fix. Men who approach it as a six-month intervention before returning to previous habits will, on average, return to their previous weight.

This is not a criticism of the drug — it is a clarification of how chronic disease management works. Obesity has a strong physiological component, and the hormonal and neurological drivers of weight regain remain active after fat loss regardless of how that loss was achieved. The practical takeaway is that if you begin semaglutide, the conversations with your prescriber should include what a long-term maintenance plan looks like — whether that means staying on the medication, transitioning to a lower dose, or building enough lifestyle infrastructure that stopping becomes viable without full regain.

It is also worth understanding where semaglutide fits in the evolving landscape of GLP-1 and dual-agonist therapies. A 2025 head-to-head trial published in the New England Journal of Medicine — the SURMOUNT-5 study — found that tirzepatide, a dual GIP/GLP-1 receptor agonist, produced greater weight loss than semaglutide at 72 weeks (-20.2% vs. -13.7%) in adults with obesity but without type 2 diabetes. This does not make semaglutide obsolete — for many men it remains highly effective, better tolerated, and more accessible — but it does inform the conversation you should have with your doctor about which agent best fits your specific metabolic profile and goals.

For men who are not candidates for or not interested in injectable therapy, the oral semaglutide space is also advancing. A 2025 trial found that oral semaglutide at 25 mg daily produced a mean weight reduction of 13.6% over 64 weeks — clinically meaningful results that rival earlier injectable data, though gastrointestinal side effects remained common.

Maximizing Results: What the Drug Cannot Do Alone

Every major semaglutide trial has been conducted alongside lifestyle intervention — and that pairing is intentional. The drug suppresses appetite and reduces caloric intake, but it does not selectively preserve muscle mass. Men on semaglutide who are not resistance training and eating sufficient protein risk losing a significant portion of their weight as lean tissue rather than fat. This is not a hypothetical concern — it is a well-documented pattern in rapid weight loss contexts. Aim for at least 0.7 to 1 gram of protein per pound of body weight daily, prioritize resistance training three to five days per week, and treat sleep and stress management as non-negotiable inputs that affect hunger hormones directly.

The injection itself is the easy part. The discipline is in treating semaglutide as a metabolic accelerant layered on top of solid fundamentals — not as a substitute for them. Men who do this consistently are the ones who look back after a year and barely recognize the before photos.

The Takeaway

Semaglutide injections work — the clinical evidence is unambiguous on that point. But using them well means following the escalation protocol faithfully, planning for long-term use rather than a quick fix, rotating injection sites, staying on top of protein and resistance training, and having honest conversations with your prescriber about your goals and timeline. The needle is just the beginning of the work.